Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Hair loss in postmenopausal woman caused by ovarian issue.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Chemotherapy causes complex changes in hair follicle cells that can lead to hair loss.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

AMH levels are higher in women with PCOS and can indicate the number of small follicles in their ovaries.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

A woman with acne and baldness was found to have a rare ovarian condition but successfully had a child through fertility treatment.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Homoeopathic treatment may help manage polycystic ovarian syndrome.

Vitamin E helps reduce PCOS symptoms and improves hormonal balance.

Ayurvedic treatment helped a woman with PCOS resume regular periods and improve symptoms without side effects.

Metformin may help regulate periods and cause modest weight loss in PCOS patients, but more research is needed.

Early diagnosis and treatment of PCOS can prevent complications and improve symptoms.

Autoimmune and inflammatory processes are involved in both scarring and non-scarring types of hair loss.

Pregnancy can cause skin darkening, varicose veins, more sweating, hair growth, hair loss after birth, nail changes, and gum inflammation.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Most skin changes during pregnancy go away after giving birth.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

The document suggests a new model for evaluating public research that better captures the full value of knowledge creation and use, using PCOS research as an example.

Many young Australian women think they have PCOS, but only a few are diagnosed correctly, causing unnecessary worry.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.